2023
DOI: 10.1002/mdc3.13695
|View full text |Cite
|
Sign up to set email alerts
|

Post‐COVID‐19 Myoclonus‐Ataxia Syndrome—Is there Really a Need for Intravenous Immunoglobulin Treatment in all Cases?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…Treatment with corticosteroids seems to be equally effective, but significantly cheaper and more readily available than IVIG therapy. Therefore, we suggest starting with steroids and only in a case of non-responsiveness or contraindications following this treatment with IVIG [47].…”
Section: Ataxia/myoclonus/opsoclonus Syndromementioning
confidence: 99%
See 1 more Smart Citation
“…Treatment with corticosteroids seems to be equally effective, but significantly cheaper and more readily available than IVIG therapy. Therefore, we suggest starting with steroids and only in a case of non-responsiveness or contraindications following this treatment with IVIG [47].…”
Section: Ataxia/myoclonus/opsoclonus Syndromementioning
confidence: 99%
“…3). Apart from these reports, tremor coexisted in 17 patients with ataxia-myoclonus syndrome (AMS), opsoclonus-myoclonus-ataxia syndrome (OMAS), and opsoclonus-myoclonus syndrome (OMS)limb tremor four [13,22,44,45], voice tremor in nine [10,15,23,27], and limb tremor combined with voice tremor in four [25,26,44,47] (Tab. 1).…”
Section: Tremormentioning
confidence: 99%